Merck trumps earnings expectations, rears sales expectation on tough requirement for leading medications like Keytruda - CNBC

.Merck defeats incomes requirements, brings up sales outlook on tough requirement for leading medicines like Keytruda CNBCMerck &amp Co. (MRK US) Beats Income Estimates as Keytruda Sales Growth BloombergMerck Sell: Pharma Giant Posts Solid End Results, Yet Overview Tumbles Short Entrepreneur's Company DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck trumps revenue and sales assumptions amid Keytruda strong point, yet gives blended full-year outlook MarketWatch.